Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sezary syndrome

被引：12
|
作者：
Gibbs, SDJ
Herbert, KE
McCormack, C
Seymour, JF
Prince, HM
机构：
[1] Peter MacCallum Canc Inst, Dept Haematol, Haematol Serv, Melbourne, Vic 8006, Australia
[2] St Vincents Hosp, Dept Dermatol, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2004年 / 73卷 / 06期
关键词：
alemtuzumab; chronic lymphocytic leukaemia; Sezary syndrome; pancytopenia;
D O I：
10.1111/j.1600-0609.2004.00332.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The simultaneous presentation of chronic lymphocytic leukaemia (CLL) and cutaneous T-cell lymphoma (CTCL) is a very rare occurrence where optimal treatment is unknown. We present the case of a 65-yr-old man who was successfully treated with alemtuzumab monotherapy for both disorders, but at a cost of severe infectious morbidity and prolonged pancytopenia.
引用
收藏
页码：447 / 449
页数：3
相关论文
共 50 条
  • [41] Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia
    Wall, DMP
    ElOsta, S
    Tzelepis, D
    Bertoncello, I
    Kantharidis, P
    Chou, ST
    Zalcberg, JR
    Parkin, JD
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (04) : 697 - 707
  • [42] Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia
    Jeanette Lundin
    Claes Karlsson
    Fredrik Celsing
    Medical Oncology, 2006, 23 (1) : 137 - 139
  • [43] Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab
    B Royer
    I Vaida
    A Etienne
    R Garidi
    G Damaj
    J P Marolleau
    Leukemia, 2007, 21 : 1841 - 1842
  • [44] The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia
    Tarnani, M.
    D'Arena, G.
    Efremov, D. G.
    Marietti, S.
    Sica, S.
    Leone, G.
    Laurenti, L.
    LEUKEMIA, 2010, 24 (04) : 890 - 891
  • [45] Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab
    Royer, B.
    Vaida, I.
    Etienne, A.
    Garidi, R.
    Damaj, G.
    Marolleau, J. P.
    LEUKEMIA, 2007, 21 (08) : 1841 - 1842
  • [46] Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia
    Lundin, J
    Karlsson, C
    Celsing, F
    MEDICAL ONCOLOGY, 2006, 23 (01) : 137 - 139
  • [47] The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia
    M Tarnani
    G D'Arena
    D G Efremov
    S Marietti
    Sica S
    G Leone
    L Laurenti
    Leukemia, 2010, 24 : 890 - 891
  • [48] Bone marrow assessment in B-cell chronic lymphocytic leukaemia: Aspirate or biopsy?
    Jarque, I
    Larrea, L
    Gomis, F
    Sanz, GF
    Martin, G
    Martinez, JA
    Sanz, MA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (04) : 754 - 755
  • [49] Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia - The Hunting of the Snark?
    Shapiro, Howard M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (05) : 772 - 773
  • [50] IL-10 serum levels in B-cell chronic lymphocytic leukaemia
    Sjoberg, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (01) : 212 - 212
12345